Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.

Safety and antigenicity of a purified preparation of Salmonella typhosa Vi antigen was evaluated in human volunteers. Dosages of Vi antigen at 25, 50, and 100 mug were less toxic than U.S. standard typhoid vaccine (lot 6A) containing 5 X 10(8) bacteria per dosage. Vi antigen in comparison with the s...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Levin, D M, Wong, K H, Reynolds, H Y, Sutton, A, Northrup, R S
Médium: Artigo
Jazyk:Inglês
Vydáno: 1975
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC415434/
https://ncbi.nlm.nih.gov/pubmed/54336
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky